Dec 06, 2023 / 01:00PM GMT
Dave Connolly - IQ Consulting, Inc. - IR
Thank you, everybody, for coming. I'm Dave Connolly here at Rhythm Pharmaceuticals, and thanks for coming to our R&D event this morning. We issued a press release today that provides details on today's update on MC4R pathway programs, and it is available on our website.
Our forward-looking statements disclosure slide here on slide 2, please read them. And with that in mind, I'll remind you, this event contains remarks concerning future expectations, plans, prospects which constitute forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those discussed in our most recent annual or quarterly reports on file with the SEC. In addition, any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent dates. And we specifically disclaim any obligation to update such statements.
As a brief overview of today's event, I'll briefly introduce each of today's
Rhythm Pharmaceuticals Inc To Discuss On MC4R Pathway Programs Call Transcript
Dec 06, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers